US2241331A - Suppository - Google Patents
Suppository Download PDFInfo
- Publication number
- US2241331A US2241331A US253224A US25322439A US2241331A US 2241331 A US2241331 A US 2241331A US 253224 A US253224 A US 253224A US 25322439 A US25322439 A US 25322439A US 2241331 A US2241331 A US 2241331A
- Authority
- US
- United States
- Prior art keywords
- suppositories
- sorbitol
- suppository
- base
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000829 suppository Substances 0.000 title description 60
- 239000002585 base Substances 0.000 description 33
- 235000014113 dietary fatty acids Nutrition 0.000 description 33
- 239000000194 fatty acid Substances 0.000 description 33
- 229930195729 fatty acid Natural products 0.000 description 33
- 238000002844 melting Methods 0.000 description 30
- 230000008018 melting Effects 0.000 description 30
- 239000003814 drug Substances 0.000 description 24
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 22
- 150000002148 esters Chemical class 0.000 description 22
- -1 sorbi-tan Chemical class 0.000 description 22
- 239000000600 sorbitol Substances 0.000 description 22
- 235000010356 sorbitol Nutrition 0.000 description 22
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 239000003981 vehicle Substances 0.000 description 18
- 150000004665 fatty acids Chemical class 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 16
- 235000019441 ethanol Nutrition 0.000 description 13
- UHGGERUQGSJHKR-VCDGYCQFSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;octadecanoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCCCCCCCCCCCC(O)=O UHGGERUQGSJHKR-VCDGYCQFSA-N 0.000 description 12
- 239000012530 fluid Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 12
- 150000005846 sugar alcohols Chemical class 0.000 description 12
- 239000002511 suppository base Substances 0.000 description 12
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 230000008961 swelling Effects 0.000 description 10
- 229930195725 Mannitol Natural products 0.000 description 9
- 150000008064 anhydrides Chemical class 0.000 description 9
- 239000003995 emulsifying agent Substances 0.000 description 9
- 239000000594 mannitol Substances 0.000 description 9
- 235000010355 mannitol Nutrition 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 7
- 229910052797 bismuth Inorganic materials 0.000 description 7
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 7
- 229940049964 oleate Drugs 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229920000569 Gum karaya Polymers 0.000 description 6
- 241000934878 Sterculia Species 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000000231 karaya gum Substances 0.000 description 6
- 235000010494 karaya gum Nutrition 0.000 description 6
- 229940039371 karaya gum Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000080 wetting agent Substances 0.000 description 6
- 229940110456 cocoa butter Drugs 0.000 description 5
- 235000019868 cocoa butter Nutrition 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229940100515 sorbitan Drugs 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- TXQVDVNAKHFQPP-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)CO TXQVDVNAKHFQPP-UHFFFAOYSA-N 0.000 description 4
- 239000010775 animal oil Substances 0.000 description 4
- 239000012164 animal wax Substances 0.000 description 4
- 229940059904 light mineral oil Drugs 0.000 description 4
- 229960004418 trolamine Drugs 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 239000012178 vegetable wax Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 3
- 229960005215 dichloroacetic acid Drugs 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 150000002895 organic esters Chemical class 0.000 description 3
- 229940059574 pentaerithrityl Drugs 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 235000020238 sunflower seed Nutrition 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000014150 Myroxylon pereirae Nutrition 0.000 description 2
- 244000302151 Myroxylon pereirae Species 0.000 description 2
- 240000001058 Sterculia urens Species 0.000 description 2
- 235000015125 Sterculia urens Nutrition 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 201000008100 Vaginitis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- JAONZGLTYYUPCT-UHFFFAOYSA-K bismuth subgallate Chemical compound OC(=O)C1=CC(O)=C2O[Bi](O)OC2=C1 JAONZGLTYYUPCT-UHFFFAOYSA-K 0.000 description 2
- 229960000199 bismuth subgallate Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000012184 mineral wax Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 2
- 229940066675 ricinoleate Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 229940118846 witch hazel Drugs 0.000 description 2
- 150000003752 zinc compounds Chemical class 0.000 description 2
- ICLYJLBTOGPLMC-KVVVOXFISA-N (z)-octadec-9-enoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O ICLYJLBTOGPLMC-KVVVOXFISA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- HKGKYUVCADNOOC-UHFFFAOYSA-N 1-aminotetradecan-2-ol Chemical compound CCCCCCCCCCCCC(O)CN HKGKYUVCADNOOC-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 241000349731 Afzelia bipindensis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940124326 anaesthetic agent Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940124572 antihypotensive agent Drugs 0.000 description 1
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- BHKPHCKISVSDGV-UHFFFAOYSA-N benzoic acid 8-quinolinyl ester Chemical compound C=1C=CC2=CC=CN=C2C=1OC(=O)C1=CC=CC=C1 BHKPHCKISVSDGV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 150000001622 bismuth compounds Chemical class 0.000 description 1
- ORZGULPODBRYCV-UHFFFAOYSA-M bismuth;oxygen(2-);iodide Chemical compound [O-2].[I-].[Bi+3] ORZGULPODBRYCV-UHFFFAOYSA-M 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 229940117013 triethanolamine oleate Drugs 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/15—Suppositories
Definitions
- This invention relates to improved suppositories. It relates more particularly to improved suppositories having a base including, as a principal ingredient, an ester of apolyhydric alcohol having four to six hydroxyl groups or an anhydride thereof, particularly an ester of a sugar alcohol, or a mixture of such esters.
- Suppositories are widely used for various types of medical-treatment, including the treatment of hemorrhoids and other rectal conditions, vaginitis, leucorrhea, constipation, etc, as well as for the administration of drugs or other therapeutic agents intended to be absorbed, as for narcosis and the like.
- the suppository vehicles or bases most commonly used include glycerin, gelatin,
- Cocoa butter which is approximately the same as that of body temperature, is widely used. Such oily or fatty compositions as cocoa butter have many objectionable properties. With certain medicaments, they tend to mask or hinder the action of the drug and interfere with the treatment, so that in many cases administration is inaccurate, unreliable, and in some cases, where such hindrance is extreme, may even be completely prevented. Cocoa butter on melting yields an odorous yellow oily material which tends to leak out of the body cavities. Its oily nature tends to prevent contact of water soluble medicaments with the mucous membranes, and to hold oil soluble medicaments in solution so that they are not readily available to the parts to be treated.
- the present invention provides suppository vehicles or bases which have important advantages over previously proposed or used suppository vehicles or bases and which permit more effective and reliable suppository medication.
- the suppository bases or vehicles of the invention while unctuous and plastic, are not oily or fatty in namm, 1. e., they have the plasticity and unctuousness required for a suppository base, but are hydrophilic rather than hydrophobic in nature. They are capable of absorbing substantial quantitles of water. Their melting point and viscosity after melting is readily adjusted so that a suppository having a proper melting point and fluidity in use is readily prepared irrespective of the relatively inexpensive and has a melting point nitan, mannide, etc.
- the new suppository bases or vehicles are not of an oily or fatty nature, they may be .used with either water soluble or oil soluble medicaments. or, insoluble medicaments, with the important advantage that irrespective of the nature oi the medicaments, it is carried in the suppository in a condition such that it is readily available and capable of contact with, or absorption by, the mucous membranes of the body cavities.
- the capacity of the new vehicle orbase for absorbing water, and of swelling to a bulk which may be several times greater than its originalbulk is an important advantage, both because it permits penetration of the suppository body by the aqueous fluids oi the body for extraction of any medicaments from the suppository base or vehicle by permeation and difiusion of the water soluble materials and because the swelling of the suppository base conforms it to the shape of the body cavity or canal, bringing it into constant, intimate contact with the mucous membranes and bringing about more eilective medication.
- the ready adjustment of the melting point of the suppository bases or vehicles of the invention is an important advantage, because it-permits the productionoi suppositories containing a wide variety of therapeutic materials, some of which may effect the melting point and some of which may not, all having the property of melting at body temperature.
- suppositories are prepared with the use of a suppository base or vehicle containing, as a principal constituent, an organic ester of a p y ydric a1- cohol having from four to six hydroxyl groups or an anhydride of such an alcohol, derived therefrom by the removal of one or two molecules of water, such as the organic esters of penta-erythritol, erythri tol, mannitol, sorbitol, dulcitol, iditol, talitol, arabitol, xylitol, etc., as well as their anhydrides, including sorbi-tan, man-
- the organic esters of the sugar alcohols have important advantages for use in preparing the new suppositories.
- sugar alcohol we mean those alcohols which correspond to the tetroses, pentcses and hexoses, including not only .the tetrahydric, penta-hydric and hexahydric alcohols, but also their anhydrides, including the alcohols derived from such pentahydric or hexahydric alcohols by the removal of oneor twomolecules of water, and mixtures which may contain one or more of the pentahydric or hexahydric alcohols, and one or more of the anhydridesof such alcohols. Included among thesugar alcoholsare ,niannitol,
- esters are unctuous bodies, having v ying melting points, depending upon the particular alcohol, the particular acid or acids used in. esterifying, and the degree of esteriflcation, that is, whether the ester is a mono-acid ester, a di-acid ester, etc.
- an emulsifying or wetting agent such agents increase the capacity of the ester base to absorb water and swell, and also increase the permeation or penetration of the base by aqueous liquids and hence increase the rate of transfer of water soluble or othermedicaments from the suppository base to the mucous membranes.
- the emulsifying or wetting agents which may be used with advantage are the gums, such as gum trasacanth, gum acacia, karaya gum, etc., soaps, including the ordinary sodium soaps, such as sodium palmitate or oleate, the amsuperglycerinated fats, stearate, fatty acid esters of ethyleneglycol and hydroxypolyalkylene oxides, such as glycol monostearate, glycol mono-oleate,
- esters used in forming the suppository base or vehicle has a melting point which is too high or too low for the production or! a suppository with a proper melting point, giving due consideration to the effect of any medicament used upon the melting point, it is readily adjusted by the addition of a suitable modifying agent, such as a petroleum; oil or wax, e. 8-. light mineral oil U. 8.
- a suitable modifying agent such as a petroleum; oil or wax, e. 8-. light mineral oil U. 8.
- paraflin or ceresine or b the addition of a vegetable or animal wax, such as carnauba wax, spermaoetti or beeswax, bythe additionof avegetableor animal oil such as sunflower seed oil by the addition such as ethyl palmitate, butyl stearate. ethyl laurate, methyl undecylineate, ethyl myristate, or the mixed esters of fatty acids derived from animal or vegetable oils with low molecular weight alcohols such as methyl alcohol, ethyl alcohol, etc.
- a vegetable or animal wax such as carnauba wax, spermaoetti or beeswax
- avegetableor animal oil such as sunflower seed oil by the addition such as ethyl palmitate, butyl stearate.
- the mixed ethyl esters of the fatty acids derived from sunflower seed oil have important advantages for use as an agent to lower the melting point of a high melting ester in a suppository base because these mixed ethyl esters do not tend to exude and because they blend very well with other ingredients used in suppositories.
- the suppositories will ordinarily include one or more therapeutic agents, such as antiseptics, anaesthetics, analgesics, healing agents, vaso-pressor compounds, alkaloids, as'tringents, bismuth or zinc compounds, etc., either intended for medication by local application or for absorption. through the mucous membrances.
- therapeutic agents such as antiseptics, anaesthetics, analgesics, healing agents, vaso-pressor compounds, alkaloids, as'tringents, bismuth or zinc compounds, etc.
- the suppositories may include such local anaesthetics as piperidlno-propanediol-diphenyl-urethrane, such antiseptics as organic mercurials, ammonium salts, oiwquinoline benzoate, ethylmeta-amino-parahydroxy benzoate, etc., such bismuth compounds as bismuth subiodide, bismuth subgallate, bismuth resorcinate, and bismuth iodotannate, zinc oxide, tannic acid, witch hazel extract, etc., intended for the treatment of hemorrhoids, vaginitis, leucorrhea, etc., by local application, as well as products such as the barbiturates, chloral hydrate and the like intended to be absorbed through the mucous membranes.
- local anaesthetics as piperidlno-propanediol-diphenyl-urethrane
- suppository medication with the use of such products is greatly improved where the new bases or vehicles of the present invention are used, both because of improved transfer of the med; rents from the vehicle or baseto the mucous membranes or the aqueous fluids in which they are bathed, because of the increase in contact between the walls of the body cavity and the suppositories and because of the desirable physical properties and proper melting point of the suppositories.
- the higher fatty acid esters of sorbitol and mannitoL- that is, the esters of sorbitol and mannitol with fatty acids having at least twelve carbon atoms and ordinarily derived from the naturally occurring fats and oils, and particularly sorbitol and mannitol stearate, laurate. oleate. and ricinoieate, have important advantages for the production of suppository bases or vehicles in accordance with the present invention.
- sorbitol stearates and oleates are commercially available at relatively low prices, are quite stable, lend themselves to the preparation of suppositories which readily absorb or emulsify with relatively large amounts of water to swell and conform to the shape of the body cavities, readily yield medicaments to the aqueous fluids, are free from disagreeable odor and are completely bland and unctuous.
- the commercially available esters e. g., sorbitol stearate, consist of mixtures of mono-, diand tri-acid esters of sorbitol and sorbitan, produced by reaction of sorbitol with the fatty acid in the presence of a small amount of an acid catalyst, or in other ways.
- sorbitol stearate in the present a,241,ss1
- the sorbitol stearates may be produced with relatively high melting points, for example, about40 to 50 0., or may be produced with lower melting points, for example, such that they are liquid at ordinary room temperatures.
- the melting points of the final suppositories in which sorbitol stearate is employed as a base or vehicle is readily adjusted by the addition of mineral oilsor waxes or vegetable or animal oils or waxes, alkyl esters of .fatty acids, etc.
- the melting point of the sorbitol stearate will depend largely upon the extent of the esterification, that is, on the proportion of the mono-, diand tri-stearates of the sorbitol and sorbitan present, and also upon the extent to which anhydrides of sorbitol, that is, sorbitan and its esters are present in the product.
- sorbitol oleates and ricinoleates which similarly have important advantages for use in the present invention, in general are liquid at body and somewhat lower temperatures, and the melting point of suppositories in which sorbitol oleate or ricinoleate is used as a base or vehicle may be adjusted by the addition of mineral, vegetable or animal waxes, or medicaments which raise the melting point, so that the final product has the proper melting point for a suppository.
- the corresponding mannitol derivatives are almost identical in their properties, and
- a wetting agent such as triethanolamine oleate and a gum, such as karaya
- a wetting agent such as triethanolamine oleate and a gum, such as karaya
- a wetting agent such as triethanolamine oleate
- a gum such as karaya
- the following examples illustrate specific suppository compositions which embody the invention and involve the use of sorbitol stearate or sorbitol oleate as a base or vehicle; but it will be understood that the invention is not limited thereto, but includes suppositories having a base made from any one or more of the wide range of sugar alcohol esters described above, together with one or more of the various wetting or dispersing agents, modifying agents, such as mineral oils, or waxes, vegetable oils or waxes, animal oils or waxes, other or different medicaments, etc.
- Penta-erythritol stearate 37.5 Paraflln (M. P. 50 C.) 6.0 Light mineral oil (U. S. P.) 37.
- Triethanolamine 1. 50 Oleic acid 3. 0 Karaya gum, powd 2. 5
- a base or vehicle which has important ad vantages for use in suppositories has the general approximate formula:
- the proportions of sorbitol stearate, paraflin, mineral oil, etc. in this formula may be varied over a relatively wide range, and'may be adjusted foruse with various medicaments to givea'suppository of proper melting point. For example, if medicaments which tend to increase the melting point are incorporated, the proportion of sorbitol stearate. or paraflln, or both may be decreased and the proportion of mineral oil increased, or other agents, such as liquid fatty acid esters, may be added to compensate for the increase in melting point caused by the medicant.
- Use of the corresponding mannitol derivative in place of the sorbitol derivative in the foregoing general formula gives products almost identical with those of the examples.
- Penta-erythritol stearate having a melting point of about 47 to 55 C. and a desirable consistency may also be used with advantage, with proper modiflcation of the proportions of the other constituents to give the flnal suppository the proper melting point.
- Mannitol mono laurate and penta erythritol ricinoleate, viscous liquids may also be used, with addition of proper modifying agents, as may the wide range of esters referred to above.
- Suppositories which have the propertie of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a basecontaining as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the clas consisting of polyhydric alcohols having an unbroken carboniinked chain and having four to six hydroxyl groups and their anhydrides.
- Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient anunctuous fatty acid ester of a fatty acid having at. least twelve carbon atoms with a sugar alcohol.
- Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient an unctuous fatty acids ester of a compound of the class consisting of polyhydric alcohols having an unbroken carbon-linked chain and having four to six hydroxyl groups and their anhydrides, said base also including an emulsifying agent.
- Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a sugar alcohol, said base also including an emulsifying agent.
- Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the class consisting of polyhydric alcohols having an unbroken carbonllnked chain and having four to six hydroxyl groups and their anhydrides, said base also containing an emulsifying agent and an oleaginous material.
- Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids.
- said suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a sugar alcohol, said base also containing an emulsifying agent and an oleaginous material.
- Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositorie having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with'a sugar alcohol, said alkyl ester of a higher fatty acid.
- Suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the class consisting of sorbitol and mannitol.
- Suppositories having a base containing as a principal ingredient a fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the clas consisting of sorbitol and mannitol.
- Suppositories having a base containing a a principal ingredient a compound of the class consisting of sorbitol stearate and mannitol stearate.
- Suppositories having a base containing as a sisting of sorbitol oleate and mannitol oleate.
- Suppositories having a base containing as a principal ingredient a fatty acid ester of a fatty acid having at least twelve carbon atoms wit: a compound of the class consisting of manmtol and sorbitol, said base also including an emulsifying agent and an added oleaginous material of the class consisting of hydrocarbon oils and waxes, vegetable and animal oils, vegetable and animal waxes and alkyl esters of -iigher fatty acids.
- Suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with penta-erythritol.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
Description
Patented May 6,1941
NITED-f STATE "sorrosrroay mm s. Shelton, inn-1mm, and Louis ma;
Beading, Ohio, assignors 'to The Wm.
$.Merrell Company, Reading, Ohio, acorporationofDelaware No Drawing. Application January Serial N- 253,22
lficlaims.
This invention relates to improved suppositories. It relates more particularly to improved suppositories having a base including, as a principal ingredient, an ester of apolyhydric alcohol having four to six hydroxyl groups or an anhydride thereof, particularly an ester of a sugar alcohol, or a mixture of such esters.
Suppositories are widely used for various types of medical-treatment, including the treatment of hemorrhoids and other rectal conditions, vaginitis, leucorrhea, constipation, etc, as well as for the administration of drugs or other therapeutic agents intended to be absorbed, as for narcosis and the like. The suppository vehicles or bases most commonly used include glycerin, gelatin,
soap, cocoa butter, etc. Cocoa butter, which is approximately the same as that of body temperature, is widely used. Such oily or fatty compositions as cocoa butter have many objectionable properties. With certain medicaments, they tend to mask or hinder the action of the drug and interfere with the treatment, so that in many cases administration is inaccurate, unreliable, and in some cases, where such hindrance is extreme, may even be completely prevented. Cocoa butter on melting yields an odorous yellow oily material which tends to leak out of the body cavities. Its oily nature tends to prevent contact of water soluble medicaments with the mucous membranes, and to hold oil soluble medicaments in solution so that they are not readily available to the parts to be treated. Many common therapeutic agents, particularly such insoluble solids as the bismuth or zinc compounds increase the viscosity of melted cocoa butter and prevent ready liquefaction oi the mixture in the body, with the result that the medicament may not be released, but may be held in the agglomerated lump of the suppository, and may be excreted without exerting its therapeutic effect.
The present invention provides suppository vehicles or bases which have important advantages over previously proposed or used suppository vehicles or bases and which permit more effective and reliable suppository medication. The suppository bases or vehicles of the invention, while unctuous and plastic, are not oily or fatty in namm, 1. e., they have the plasticity and unctuousness required for a suppository base, but are hydrophilic rather than hydrophobic in nature. They are capable of absorbing substantial quantitles of water. Their melting point and viscosity after melting is readily adjusted so that a suppository having a proper melting point and fluidity in use is readily prepared irrespective of the relatively inexpensive and has a melting point nitan, mannide, etc.
nature of the medicament which it cont n- As the new suppository bases or vehicles are not of an oily or fatty nature, they may be .used with either water soluble or oil soluble medicaments. or, insoluble medicaments, with the important advantage that irrespective of the nature oi the medicaments, it is carried in the suppository in a condition such that it is readily available and capable of contact with, or absorption by, the mucous membranes of the body cavities. The capacity of the new vehicle orbase for absorbing water, and of swelling to a bulk which may be several times greater than its originalbulk is an important advantage, both because it permits penetration of the suppository body by the aqueous fluids oi the body for extraction of any medicaments from the suppository base or vehicle by permeation and difiusion of the water soluble materials and because the swelling of the suppository base conforms it to the shape of the body cavity or canal, bringing it into constant, intimate contact with the mucous membranes and bringing about more eilective medication. The ready adjustment of the melting point of the suppository bases or vehicles of the invention is an important advantage, because it-permits the productionoi suppositories containing a wide variety of therapeutic materials, some of which may effect the melting point and some of which may not, all having the property of melting at body temperature.
In accordance with the present invention, suppositories are prepared with the use of a suppository base or vehicle containing, as a principal constituent, an organic ester of a p y ydric a1- cohol having from four to six hydroxyl groups or an anhydride of such an alcohol, derived therefrom by the removal of one or two molecules of water, such as the organic esters of penta-erythritol, erythri tol, mannitol, sorbitol, dulcitol, iditol, talitol, arabitol, xylitol, etc., as well as their anhydrides, including sorbi-tan, man- The organic esters of the sugar alcohols have important advantages for use in preparing the new suppositories. By the term sugar alcohol, we mean those alcohols which correspond to the tetroses, pentcses and hexoses, including not only .the tetrahydric, penta-hydric and hexahydric alcohols, but also their anhydrides, including the alcohols derived from such pentahydric or hexahydric alcohols by the removal of oneor twomolecules of water, and mixtures which may contain one or more of the pentahydric or hexahydric alcohols, and one or more of the anhydridesof such alcohols. Included among thesugar alcoholsare ,niannitol,
of one or more equivalents of the acid withone mole of the alcohol, with the production of monoacid esters, di-acid esters, tri-acid esters, etc., and mixtures of these various esters of a more or less complex nature. These esters are unctuous bodies, having v ying melting points, depending upon the particular alcohol, the particular acid or acids used in. esterifying, and the degree of esteriflcation, that is, whether the ester is a mono-acid ester, a di-acid ester, etc.
liquid at ordinary temperatures or body temperatures, whereas others, for example, sorbitol stearate and penta-erythritol stearate, have melting points as high as about 50 0., or even higher. The melting points of the bemodifledbyadmixtureoftwoormoreesters, or by the addition of other modifying agents as will be hereinafter explained.
Along with the alcohol ester or esters it is advantageous to include in the suppository base or vehicle an emulsifying or wetting agent. Such agents increase the capacity of the ester base to absorb water and swell, and also increase the permeation or penetration of the base by aqueous liquids and hence increase the rate of transfer of water soluble or othermedicaments from the suppository base to the mucous membranes. Among the emulsifying or wetting agents which may be used with advantage are the gums, such as gum trasacanth, gum acacia, karaya gum, etc., soaps, including the ordinary sodium soaps, such as sodium palmitate or oleate, the amsuperglycerinated fats, stearate, fatty acid esters of ethyleneglycol and hydroxypolyalkylene oxides, such as glycol monostearate, glycol mono-oleate,
products of oleic acid and mono-ethanoiamine, etc. It is advaninclude both a gum. and a wetting algent, e. g., Karaya gum and triethanolamm' e Where the ester used in forming the suppository base or vehicle has a melting point which is too high or too low for the production or! a suppository with a proper melting point, giving due consideration to the effect of any medicament used upon the melting point, it is readily adjusted by the addition of a suitable modifying agent, such as a petroleum; oil or wax, e. 8-. light mineral oil U. 8. P., paraflin or ceresine, or b the addition of a vegetable or animal wax, such as carnauba wax, spermaoetti or beeswax, bythe additionof avegetableor animal oilsuch as sunflower seed oil by the addition such as ethyl palmitate, butyl stearate. ethyl laurate, methyl undecylineate, ethyl myristate, or the mixed esters of fatty acids derived from animal or vegetable oils with low molecular weight alcohols such as methyl alcohol, ethyl alcohol, etc. The mixed ethyl esters of the fatty acids derived from sunflower seed oil have important advantages for use as an agent to lower the melting point of a high melting ester in a suppository base because these mixed ethyl esters do not tend to exude and because they blend very well with other ingredients used in suppositories.
Along with the polyhydric alcohol ester, and advantageously an emulsifying or wetting agent, with such melting point modifying agent as my be necessary or desirable, the suppositories will ordinarily include one or more therapeutic agents, such as antiseptics, anaesthetics, analgesics, healing agents, vaso-pressor compounds, alkaloids, as'tringents, bismuth or zinc compounds, etc., either intended for medication by local application or for absorption. through the mucous membrances. Thus the suppositories may include such local anaesthetics as piperidlno-propanediol-diphenyl-urethrane, such antiseptics as organic mercurials, ammonium salts, oiwquinoline benzoate, ethylmeta-amino-parahydroxy benzoate, etc., such bismuth compounds as bismuth subiodide, bismuth subgallate, bismuth resorcinate, and bismuth iodotannate, zinc oxide, tannic acid, witch hazel extract, etc., intended for the treatment of hemorrhoids, vaginitis, leucorrhea, etc., by local application, as well as products such as the barbiturates, chloral hydrate and the like intended to be absorbed through the mucous membranes. In any event, suppository medication with the use of such products is greatly improved where the new bases or vehicles of the present invention are used, both because of improved transfer of the med; rents from the vehicle or baseto the mucous membranes or the aqueous fluids in which they are bathed, because of the increase in contact between the walls of the body cavity and the suppositories and because of the desirable physical properties and proper melting point of the suppositories.
The higher fatty acid esters of sorbitol and mannitoL- that is, the esters of sorbitol and mannitol with fatty acids having at least twelve carbon atoms and ordinarily derived from the naturally occurring fats and oils, and particularly sorbitol and mannitol stearate, laurate. oleate. and ricinoieate, have important advantages for the production of suppository bases or vehicles in accordance with the present invention. The sorbitol stearates and oleates are commercially available at relatively low prices, are quite stable, lend themselves to the preparation of suppositories which readily absorb or emulsify with relatively large amounts of water to swell and conform to the shape of the body cavities, readily yield medicaments to the aqueous fluids, are free from disagreeable odor and are completely bland and unctuous. The commercially available esters, e. g., sorbitol stearate, consist of mixtures of mono-, diand tri-acid esters of sorbitol and sorbitan, produced by reaction of sorbitol with the fatty acid in the presence of a small amount of an acid catalyst, or in other ways. During such process, one or two molecules of water may split off from a portion of the sorbitol, with formation of anhydrides of sorbitol in the mixture, so that the flnal product is probably a mixture of sorbitol and sorbitan fatty acid esters. In referring to sorbitol stearate in the present a,241,ss1
application and claims; such commercially occurring mixtures are included. The sorbitol stearates may be produced with relatively high melting points, for example, about40 to 50 0., or may be produced with lower melting points, for example, such that they are liquid at ordinary room temperatures. The melting points of the final suppositories in which sorbitol stearate is employed as a base or vehicle is readily adjusted by the addition of mineral oilsor waxes or vegetable or animal oils or waxes, alkyl esters of .fatty acids, etc. The melting point of the sorbitol stearate will depend largely upon the extent of the esterification, that is, on the proportion of the mono-, diand tri-stearates of the sorbitol and sorbitan present, and also upon the extent to which anhydrides of sorbitol, that is, sorbitan and its esters are present in the product. The sorbitol oleates and ricinoleates which similarly have important advantages for use in the present invention, in general are liquid at body and somewhat lower temperatures, and the melting point of suppositories in which sorbitol oleate or ricinoleate is used as a base or vehicle may be adjusted by the addition of mineral, vegetable or animal waxes, or medicaments which raise the melting point, so that the final product has the proper melting point for a suppository. The corresponding mannitol derivatives are almost identical in their properties, and
uses. In general, with the sorbitol and mannitol oleates, stearates and ricinoleates, there are important advantages in including in the suppositories an emulsifying agent and a wetting agent,
advantageously a wetting agent such as triethanolamine oleate and a gum, such as karaya The following examples illustrate specific suppository compositions which embody the invention and involve the use of sorbitol stearate or sorbitol oleate as a base or vehicle; but it will be understood that the invention is not limited thereto, but includes suppositories having a base made from any one or more of the wide range of sugar alcohol esters described above, together with one or more of the various wetting or dispersing agents, modifying agents, such as mineral oils, or waxes, vegetable oils or waxes, animal oils or waxes, other or different medicaments, etc.
Exsmam I.-Local anaesthetic suppository Parts Sorbitol stearate (M. P. 41 C.) .r 72. Parailin (M. P. 50 C.) 8. 0 Light mineral oil (U. S. P.) 11. 9 Triethanolamine 1.5 Oleic Mid 3.0 Karaya gum, powd, 2.5 Piperidinopropanediol diphenyl urethrane free base v I i 1.0 Oxyquinoline benzoate 0.1 EXAMPLE II.Hem0rrhoid suppositories Parts Bismuth slibindide 3. 33 Bismuth subgallate 3. 33 Zinc oxide 3. 33 Resorcinol 0. 34 Balsam of Peru 1. 67 Penta-erythritol stearate 37.5 Paraflln (M. P. 50 C.) 6.0 Light mineral oil (U. S. P.) 37. Triethanolamine 1. 50 Oleic acid 3. 0 Karaya gum, powd 2. 5
- Exlmrta Ill-Astringent hemorrhoidrsuppositories Parts Bismuth iodotannate. 10.25 Bismuth resorcinate 10.25 Zinc oxide 16.40 Balsam of Peru -s 4. 10 sorbitol oleate 34.50 Ceresine (M. P. 56 C.) 17. 50 Triethanolamine 1.50 Oleic aci 3.00 Karaya gum, powd u 2.- 50 Exmu: IY.-Astrinaent hemorrhoid suppositories Suppositories are prepared with the same composition as in Exmple III, except that 17.50' parts of spermacettiare substituted for the 17.50 parts of Ceresine.
EXAMPLE VII-Witch hazel suppositories Parts Pilulae extract of Hama'melis 5.00 sorbitol stearate (M. P. 41 C.) 70.00 Paraflin (M. P. 50 C.) 7.00 Ethylated sunflower seed oil fatty acids--- 11.00 Lauryl ethanolamine sulfate-- 4.50 Karaya gum, powd 2.50
A base or vehicle which has important ad vantages for use in suppositories has the general approximate formula:
Parts sorbitol stearate (M. P. 41 C.) 73.0 Paraiiin (M. P. 50 C.) 8.0 Light mineral oil (U. S. P.) 12.0 Triethanolamine 1.5 Oleic acid 3.0 Karaya g 2.5
The proportions of sorbitol stearate, paraflin, mineral oil, etc. in this formula may be varied over a relatively wide range, and'may be adjusted foruse with various medicaments to givea'suppository of proper melting point. For example, if medicaments which tend to increase the melting point are incorporated, the proportion of sorbitol stearate. or paraflln, or both may be decreased and the proportion of mineral oil increased, or other agents, such as liquid fatty acid esters, may be added to compensate for the increase in melting point caused by the medicant. Use of the corresponding mannitol derivative in place of the sorbitol derivative in the foregoing general formula gives products almost identical with those of the examples. Penta-erythritol stearate, having a melting point of about 47 to 55 C. and a desirable consistency may also be used with advantage, with proper modiflcation of the proportions of the other constituents to give the flnal suppository the proper melting point. Mannitol mono laurate and penta erythritol ricinoleate, viscous liquids, may also be used, with addition of proper modifying agents, as may the wide range of esters referred to above.
We claim:
1. Suppositories which have the propertie of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a basecontaining as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the clas consisting of polyhydric alcohols having an unbroken carboniinked chain and having four to six hydroxyl groups and their anhydrides.
2. Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient anunctuous fatty acid ester of a fatty acid having at. least twelve carbon atoms with a sugar alcohol.
3. Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient an unctuous fatty acids ester of a compound of the class consisting of polyhydric alcohols having an unbroken carbon-linked chain and having four to six hydroxyl groups and their anhydrides, said base also including an emulsifying agent.
4. Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a sugar alcohol, said base also including an emulsifying agent.
5. Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the class consisting of polyhydric alcohols having an unbroken carbonllnked chain and having four to six hydroxyl groups and their anhydrides, said base also containing an emulsifying agent and an oleaginous material.
6. Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids. said suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a sugar alcohol, said base also containing an emulsifying agent and an oleaginous material.
"I. Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositories having a base containing as a princiswelling on contact with aqueous fluids. said suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a sugar alcohol, said base also containing a gum.
9. Suppositories which have the properties of absorbing substantial quantities of water, and swelling on contact with aqueous fluids, said suppositorie having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with'a sugar alcohol, said alkyl ester of a higher fatty acid.
10. Suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the class consisting of sorbitol and mannitol.
11. Suppositories having a base containing as a principal ingredient a fatty acid ester of a fatty acid having at least twelve carbon atoms with a compound of the clas consisting of sorbitol and mannitol.
12. Suppositories having a base containing a a principal ingredient a compound of the class consisting of sorbitol stearate and mannitol stearate. a
13. Suppositories having a base containing as a sisting of sorbitol oleate and mannitol oleate.
14. Suppositories having a base containing as a principal ingredient a fatty acid ester of a fatty acid having at least twelve carbon atoms wit: a compound of the class consisting of manmtol and sorbitol, said base also including an emulsifying agent and an added oleaginous material of the class consisting of hydrocarbon oils and waxes, vegetable and animal oils, vegetable and animal waxes and alkyl esters of -iigher fatty acids.
15. Suppositories having a base containing as a principal ingredient an unctuous fatty acid ester of a fatty acid having at least twelve carbon atoms with penta-erythritol.
16. Suppositories having a base contalningas a principal ingredient penta-erythritol stearate.
ROBERT S. SHELTON. LOUIS MAGID.
base also containing an
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US253224A US2241331A (en) | 1939-01-27 | 1939-01-27 | Suppository |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US253224A US2241331A (en) | 1939-01-27 | 1939-01-27 | Suppository |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2241331A true US2241331A (en) | 1941-05-06 |
Family
ID=22959380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US253224A Expired - Lifetime US2241331A (en) | 1939-01-27 | 1939-01-27 | Suppository |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2241331A (en) |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2469618A (en) * | 1945-09-21 | 1949-05-10 | Eaton Lab Inc | Vaginal suppository |
| US2538127A (en) * | 1948-02-26 | 1951-01-16 | Searle & Co | Medicated suppositories and bases therefor |
| US2696456A (en) * | 1950-04-24 | 1954-12-07 | Lambert Company | Dual element suppository |
| DE1015576B (en) * | 1953-12-12 | 1957-09-12 | Edelfettwerke Ges Mit Beschrae | Process for the production of suppository compounds |
| DE1113063B (en) * | 1958-08-08 | 1961-08-24 | Schlueter Edelfett | Basis for suppositories |
| US3019163A (en) * | 1959-07-13 | 1962-01-30 | Harnist Lucien | Hemorrhoidal composition |
| DE1128600B (en) * | 1958-05-22 | 1962-04-26 | Schlueter Edelfett | Basis for suppositories |
| US4335104A (en) * | 1978-08-16 | 1982-06-15 | United Chemical Corporation | Anhydrous multi-purpose moisturizing composition |
| US4338306A (en) * | 1979-05-10 | 1982-07-06 | Kyoto Yakuhin Kogyo Kabushiki Kaisha | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
| US4529601A (en) * | 1977-12-01 | 1985-07-16 | Astra Lakemedel Aktiebolag | Local anesthetic mixture for topical application and method for obtaining local anesthesia |
| WO1985004108A1 (en) * | 1984-03-19 | 1985-09-26 | Fournier E P | Prophylactic rectal douching device |
| US5021241A (en) * | 1983-10-14 | 1991-06-04 | Sumitomo Pharmaceuticals Company, Limited | Long-term sustained-release preparation |
| US20090176876A1 (en) * | 2008-01-04 | 2009-07-09 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially decolletage |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
-
1939
- 1939-01-27 US US253224A patent/US2241331A/en not_active Expired - Lifetime
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2469618A (en) * | 1945-09-21 | 1949-05-10 | Eaton Lab Inc | Vaginal suppository |
| US2538127A (en) * | 1948-02-26 | 1951-01-16 | Searle & Co | Medicated suppositories and bases therefor |
| US2696456A (en) * | 1950-04-24 | 1954-12-07 | Lambert Company | Dual element suppository |
| DE1015576B (en) * | 1953-12-12 | 1957-09-12 | Edelfettwerke Ges Mit Beschrae | Process for the production of suppository compounds |
| DE1128600B (en) * | 1958-05-22 | 1962-04-26 | Schlueter Edelfett | Basis for suppositories |
| DE1113063B (en) * | 1958-08-08 | 1961-08-24 | Schlueter Edelfett | Basis for suppositories |
| US3019163A (en) * | 1959-07-13 | 1962-01-30 | Harnist Lucien | Hemorrhoidal composition |
| US4529601A (en) * | 1977-12-01 | 1985-07-16 | Astra Lakemedel Aktiebolag | Local anesthetic mixture for topical application and method for obtaining local anesthesia |
| US4562060A (en) * | 1977-12-01 | 1985-12-31 | Astra Lakemedel Aktiebolag | Local anesthetic mixture for topical application, process for its preparation, as well as method for obtaining local anesthesia |
| US4335104A (en) * | 1978-08-16 | 1982-06-15 | United Chemical Corporation | Anhydrous multi-purpose moisturizing composition |
| US4338306A (en) * | 1979-05-10 | 1982-07-06 | Kyoto Yakuhin Kogyo Kabushiki Kaisha | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
| US5021241A (en) * | 1983-10-14 | 1991-06-04 | Sumitomo Pharmaceuticals Company, Limited | Long-term sustained-release preparation |
| WO1985004108A1 (en) * | 1984-03-19 | 1985-09-26 | Fournier E P | Prophylactic rectal douching device |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8148563B2 (en) | 2006-02-03 | 2012-04-03 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US20090176876A1 (en) * | 2008-01-04 | 2009-07-09 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially decolletage |
| US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US8505730B2 (en) | 2008-01-04 | 2013-08-13 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2241331A (en) | Suppository | |
| US3639575A (en) | Silver ion gel compositions and method of using the same | |
| US2149005A (en) | Shaped medicinal preparation | |
| US3740421A (en) | Polyoxyethylene-polyoxypropylene aqueous gels | |
| US3929985A (en) | Anhydrous candicidin foam compositions | |
| US3849569A (en) | Composition containing procaine penicillin | |
| US2372807A (en) | Absorption bases | |
| US3542919A (en) | Astringent alkali metal aluminum complexes of hydroxy acids | |
| US4164564A (en) | Ointment and cream bases capable of withstanding elevated temperatures | |
| US3259545A (en) | Stable aluminum hydroxide gel or aluminum hydroxide-sodium zirconium lactate antiperspirant stick | |
| US4680312A (en) | Stable prostaglandin E gels utilizing colloidal silicon dioxide as a gel-forming agent | |
| US2628930A (en) | Aqueous emulsions of lipoid-soluble vitamins | |
| GB645038A (en) | Astringent composition and method for preparation thereof | |
| US2538127A (en) | Medicated suppositories and bases therefor | |
| JPS60100525A (en) | Pharmaceutical composition | |
| US2566200A (en) | Oral therapeutic tablets | |
| US2055063A (en) | Suppository medication | |
| US3888995A (en) | Fatty alcohol-propylene glycol vehicle | |
| US2294140A (en) | Deodorant cream | |
| US4410517A (en) | Vitamin E (tocopherol) compositions which resemble petrolatum | |
| US2056208A (en) | Acetyl-salicylic acid composition | |
| JPH04100535A (en) | Oil in polyhydric alcohol type emulsified composition | |
| US3594473A (en) | Anti-haemorrhoidally active preparations and the use of a d-glucofuranoside in such preparations | |
| JPS5933211A (en) | Oleaginous ointment | |
| US1999161A (en) | Skin cream containing magnesium |